Charles Schwab Investment Management Inc 4 D Molecular Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 338,317 shares of FDMT stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

338,317

Previous 337,865 0.13%

Holding current value

$1.97 Million

Previous $7.09 Million 48.43%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.81 - $27.22 $4,886 - $12,303	452 Added 0.13%	338,317 $3.66 Million
Q2 2024 Aug 12, 2024	BUY	$20.93 - $30.01 $746,363 - $1.07 Million	35,660 Added 11.8%	337,865 $7.09 Million
Q1 2024 May 08, 2024	BUY	$17.03 - $35.87 $571,646 - $1.2 Million	33,567 Added 12.5%	302,205 $9.63 Million
Q4 2023 Feb 06, 2024	BUY	$9.76 - $21.25 $98,868 - $215,262	10,130 Added 3.92%	268,638 $5.44 Million
Q3 2023 Nov 08, 2023	SELL	$12.64 - $19.76 $95,672 - $149,563	-7,569 Reduced 2.84%	258,508 $3.29 Million
Q2 2023 Aug 09, 2023	BUY	$15.16 - $23.26 $727,240 - $1.12 Million	47,971 Added 21.99%	266,077 $4.81 Million
Q1 2023 May 11, 2023	BUY	$15.45 - $23.19 $18,632 - $27,967	1,206 Added 0.56%	218,106 $3.75 Million
Q4 2022 Feb 13, 2023	BUY	$6.85 - $25.46 $40,812 - $151,690	5,958 Added 2.82%	216,900 $4.82 Million
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.48 $242,493 - $399,974	34,841 Added 19.78%	210,942 $1.7 Million
Q2 2022 Aug 15, 2022	SELL	$5.68 - $15.99 $76,736 - $216,024	-13,510 Reduced 7.13%	176,101 $1.23 Million
Q1 2022 May 13, 2022	BUY	$13.16 - $22.64 $69,905 - $120,263	5,312 Added 2.88%	189,611 $2.87 Million
Q4 2021 Feb 11, 2022	BUY	$19.56 - $32.94 $765,676 - $1.29 Million	39,145 Added 26.97%	184,299 $4.04 Million
Q3 2021 Nov 16, 2021	BUY	$22.73 - $36.04 $1.86 Million - $2.95 Million	81,934 Added 129.6%	145,154 $3.92 Million
Q2 2021 Aug 16, 2021	BUY	$22.2 - $42.29 $116,616 - $222,149	5,253 Added 9.06%	63,220 $1.52 Million
Q1 2021 May 17, 2021	BUY	$35.94 - $52.67 $2.08 Million - $3.05 Million	57,967 New	57,967 $2.52 Million

Others Institutions Holding FDMT

# of Institutions

144

Shares Held

57.7M

Call Options Held

137K

Put Options Held

111K

View Full List

About 4D Molecular Therapeutics, Inc.

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $188M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

More about FDMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc 4 D Molecular Therapeutics, Inc. Transaction History